Evaluation of commercial kits for purification of circulating free DNA

Zhang, 2017, Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes?, Cell Physiol Biochem, 41, 755, 10.1159/000458736 Siravegna, 2017, Integrating liquid biopsies into the management of cancer, Nat Rev Clin Oncol, 14, 531, 10.1038/nrclinonc.2017.14 Perakis, 2017, Emerging concepts in liquid biopsies, BMC Med, 15, 75, 10.1186/s12916-017-0840-6 Underhill, 2016, Fragment length of circulating tumor DNA, PLoS Genet, 12, 10.1371/journal.pgen.1006162 Thierry, 2010, Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Res, 38, 6159, 10.1093/nar/gkq421 Lo, 2010, Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci Transl Med, 2, 61ra91, 10.1126/scitranslmed.3001720 Thierry, 2016, Origins, structures, and functions of circulating DNA in oncology, Cancer Metastasis Rev, 35, 347, 10.1007/s10555-016-9629-x Jahr, 2001, DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res, 61, 1659 Stroun, 2001, About the possible origin and mechanism of circulating DNA apoptosis and active DNA release, Clin Chim Acta, 313, 139, 10.1016/S0009-8981(01)00665-9 Wan, 2017, Liquid biopsies come of age: towards implementation of circulating tumour DNA, Nat Rev Cancer, 17, 223, 10.1038/nrc.2017.7 Cabel, 2017, Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study, Ann Oncol, 28, 1996, 10.1093/annonc/mdx212 Lee, 2017, Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma, Ann Oncol, 28, 1130, 10.1093/annonc/mdx026 Gray, 2015, Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma, Oncotarget, 6, 42008, 10.18632/oncotarget.5788 Calapre, 2017, Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma, Cancer Lett, 404, 62, 10.1016/j.canlet.2017.06.030 Cheng, 2017, Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients, Int J Cancer, 140, 2344, 10.1002/ijc.30650 Dawson, 2013, Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, 368, 1199, 10.1056/NEJMoa1213261 Diehl, 2008, Circulating mutant DNA to assess tumor dynamics, Nat Med, 14, 985, 10.1038/nm.1789 Donaldson, 2018, Circulating tumor DNA: measurement and clinical utility, Annu Rev Med, 69, 223, 10.1146/annurev-med-041316-085721 Hou, 2017, Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay, Sci Rep, 7, 14605, 10.1038/s41598-017-14962-0 Du, 2017, Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification, Oncotarget, 8, 26281, 10.18632/oncotarget.15457 Thompson, 2016, Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next-generation sequencing of cell-free circulating tumor DNA, Clin Cancer Res, 22, 5772, 10.1158/1078-0432.CCR-16-1231 Heidary, 2014, The dynamic range of circulating tumor DNA in metastatic breast cancer, Breast Cancer Res, 16, 421, 10.1186/s13058-014-0421-y Alidousty, 2017, Comparison of blood collection tubes from three different manufacturers for the collection of cell-free DNA for liquid biopsy mutation testing, J Mol Diagn, 19, 801, 10.1016/j.jmoldx.2017.06.004 van Dessel, 2017, Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions, Mol Oncol, 11, 295, 10.1002/1878-0261.12037 El Messaoudi, 2013, Circulating cell free DNA: Preanalytical considerations, Clin Chim Acta, 424, 222, 10.1016/j.cca.2013.05.022 Nikolaev, 2018, Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory, Anal Biochem, 542, 34, 10.1016/j.ab.2017.11.004 Parpart-Li, 2017, The effect of preservative and temperature on the analysis of circulating tumor DNA, Clin Cancer Res, 23, 2471, 10.1158/1078-0432.CCR-16-1691 Wong, 2013, Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing, Clin Biochem, 46, 1099, 10.1016/j.clinbiochem.2013.04.023 Warton, 2017, Evaluation of Streck BCT and PAXgene stabilised blood collection tubes for cell-free circulating DNA studies in plasma, Mol Diagn Ther, 21, 563, 10.1007/s40291-017-0284-x Warton, 2018, Comparison of 4 commercial kits for the extraction of circulating DNA from plasma, Cancer Genet, 10.1016/j.cancergen.2018.02.004 Perez-Barrios, 2016, Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing, Transl Lung Cancer Res, 5, 665, 10.21037/tlcr.2016.12.03 Sorber, 2017, A comparison of cell-free DNA isolation kits: isolation and quantification of cell-free DNA in plasma, J Mol Diagn, 19, 162, 10.1016/j.jmoldx.2016.09.009 Kloten, 2017, Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR, Oncotarget, 8, 86253, 10.18632/oncotarget.21134 Sondergaard, 2010, Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032, J Transl Med, 8, 39, 10.1186/1479-5876-8-39 Warton, 2014, Methylation-capture and next-generation sequencing of free circulating DNA from human plasma, BMC Genom, 15, 476, 10.1186/1471-2164-15-476 Jiang, 2015, Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients, Proc Natl Acad Sci USA, 112, E1317, 10.1073/pnas.1500076112 Mouliere, 2011, High fragmentation characterizes tumour-derived circulating DNA, PLoS One, 6, e23418, 10.1371/journal.pone.0023418 Mouliere, 2015, Circulating tumor-derived DNA is shorter than somatic DNA in plasma, Proc Natl Acad Sci USA, 112, 3178, 10.1073/pnas.1501321112